Rxsight Inc
rxsight.comRxSight Inc (NASDAQ: RXST) is a medical device company focused on the treatment of cataracts through a proprietary adjustable intraocular lens system. The company makes money by selling its Light Adjustable Lens (LAL) and the associated Light Delivery Device (LDD) used to customize vision after cataract surgery. The LAL system allows post-surgical adjustment of a patient's vision correction using ultraviolet light, differentiating it from fixed intraocular lenses implanted by competitors. RxSight sells its products to ophthalmologists and cataract surgery centers, primarily in the United States. The filing was made on 2026-02-25 covering the fiscal year ended in that period. Due to limited financial detail in the available filing excerpts, specific revenue figures, segment breakdowns, customer counts, and named competitors cannot be confirmed from this source and are omitted accordingly.
Products & Services
Light Adjustable Lens (LAL), a post-surgically adjustable intraocular lens; Light Delivery Device (LDD), the ultraviolet light instrument used to perform vision adjustments after LAL implantation.
Revenue Model
Product sales of the Light Adjustable Lens (LAL) and Light Delivery Device (LDD) to ophthalmic surgery providers. Based on available excerpts, specific pricing, subscription, or recurring revenue details cannot be confirmed.
Customers & Markets
Ophthalmologists and cataract surgery centers. End market is cataract surgery patients seeking customized vision correction. Specific customer concentration data not supported by available excerpts.
Geographic Exposure
Primarily United States, based on filing registration details. International exposure not confirmed by available excerpts.
Financial Snapshot
Loading...
